141 related articles for article (PubMed ID: 28605526)
1. Anti-NXP2 antibody-associated extensive subcutaneous calcinosis in adult-onset myositis.
Goulabchand R; Guilpain P; Cyteval C; Le Quellec A
Rheumatology (Oxford); 2017 Oct; 56(10):1661. PubMed ID: 28605526
[No Abstract] [Full Text] [Related]
2. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.
Tansley SL; Betteridge ZE; Shaddick G; Gunawardena H; Arnold K; Wedderburn LR; McHugh NJ;
Rheumatology (Oxford); 2014 Dec; 53(12):2204-8. PubMed ID: 24987158
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET detects extensive calcinosis cutis in anti-NXP2 antibody-positive dermatomyositis.
Nakamura N; Izumi R; Hoshi Y; Takai Y; Ono R; Suzuki N; Nagai T; Ishii Y; Ishii T; Harigae H; Okada S; Aiba S; Okiyama N; Fujimoto M; Kuroda H; Tateyama M; Aoki M
Rheumatology (Oxford); 2019 Oct; 58(10):1888. PubMed ID: 30879053
[No Abstract] [Full Text] [Related]
4. Autoantibodies to nuclear matrix protein 2/MJ in adult-onset dermatomyositis with severe calcinosis.
Sugiura K; Muro Y; Akiyama M
J Am Acad Dermatol; 2012 Oct; 67(4):e167-8. PubMed ID: 22980285
[No Abstract] [Full Text] [Related]
5. Systemic Calcinosis in NXP2-Dermatomyositis.
Martín D; Curbelo J; Moldenhauer F
J Clin Rheumatol; 2019 Jun; 25(4):e35. PubMed ID: 29319550
[No Abstract] [Full Text] [Related]
6. Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options.
Fredi M; Bartoli F; Cavazzana I; Ceribelli A; Carabellese N; Tincani A; Satoh M; Franceschini F
Clin Exp Rheumatol; 2017; 35(2):303-308. PubMed ID: 27908312
[TBL] [Abstract][Full Text] [Related]
7. Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody.
Gossez M; Levesque M; Khouatra C; Cottin V; Garnier L; Fabien N
Eur Respir Rev; 2015 Jun; 24(136):370-2. PubMed ID: 26028648
[TBL] [Abstract][Full Text] [Related]
8. Diffuse Soft-Tissue Swelling in Antinuclear Matrix Protein-2 Antibody-Associated Dermatomyositis Sine Dermatitis.
Chompoopong P; Liewluck T; McMenomy BP; Harper CM
Mayo Clin Proc; 2021 Oct; 96(10):2517-2518. PubMed ID: 34425965
[No Abstract] [Full Text] [Related]
9. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.
Ichimura Y; Matsushita T; Hamaguchi Y; Kaji K; Hasegawa M; Tanino Y; Inokoshi Y; Kawai K; Kanekura T; Habuchi M; Igarashi A; Sogame R; Hashimoto T; Koga T; Nishino A; Ishiguro N; Sugimoto N; Aoki R; Ando N; Abe T; Kanda T; Kuwana M; Takehara K; Fujimoto M
Ann Rheum Dis; 2012 May; 71(5):710-3. PubMed ID: 22258483
[TBL] [Abstract][Full Text] [Related]
10. Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan.
Iwata N; Nakaseko H; Kohagura T; Yasuoka R; Abe N; Kawabe S; Sugiura S; Muro Y
Mod Rheumatol; 2019 Sep; 29(5):802-807. PubMed ID: 30092736
[No Abstract] [Full Text] [Related]
11. A patient with anti-NXP2-positive dermatomyositis and syphilis.
Nguyen M; Hai J; Bovenberg MSS; Wilken R; Kiuru M; Brassard A; Tartar D
Dermatol Online J; 2020 Feb; 26(2):. PubMed ID: 32239891
[TBL] [Abstract][Full Text] [Related]
12. Diffuse oesophageal involvement in anti-NXP2 myositis and response to combined immunosuppressive therapy.
Fanouriakis A; Lazarini A; Sofianos I; Papadopoulos C; Bagiazidou E; Balanika A; Elezoglou A
Rheumatology (Oxford); 2021 Nov; 60(11):e378-e380. PubMed ID: 33956080
[No Abstract] [Full Text] [Related]
13. Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.
Xu Y; Ma X; Zhou Z; Li J; Hou J; Zhu J; Kang M; Lai J; Li X
Pediatr Rheumatol Online J; 2021 Jan; 19(1):2. PubMed ID: 33407602
[TBL] [Abstract][Full Text] [Related]
14. Association of anti-nuclear matrix protein 2 antibody with complications in patients with idiopathic inflammatory myopathies: A meta-analysis of 20 cohorts.
Zhong L; Yu Z; Song H
Clin Immunol; 2019 Jan; 198():11-18. PubMed ID: 30445156
[TBL] [Abstract][Full Text] [Related]
15. Anti-NXP2 antibody-positive dermatomyositis with aortic thrombus in normal aortic wall.
Tawara N; Yamashita S; Nagatoshi C; Nakajima M; Ichimura Y; Okiyama N; Ando Y
Rheumatology (Oxford); 2021 May; 60(5):e159-e161. PubMed ID: 33989423
[No Abstract] [Full Text] [Related]
16. Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis.
Aouizerate J; De Antonio M; Bader-Meunier B; Barnerias C; Bodemer C; Isapof A; Quartier P; Melki I; Charuel JL; Bassez G; Desguerre I; Gherardi RK; Authier FJ; Gitiaux C
Rheumatology (Oxford); 2018 May; 57(5):873-879. PubMed ID: 29474663
[TBL] [Abstract][Full Text] [Related]
17. Digestive vasculitis: a rare but severe complication of NXP2 dermatomyositis.
Trefond L; Smets P; Beltzung F; Olagne L; Bardy A; Aumaître O; André M
Rheumatology (Oxford); 2021 May; 60(5):e165-e166. PubMed ID: 33313929
[No Abstract] [Full Text] [Related]
18. Lacy reticular-pattern calcinosis in adult dermatomyositis.
Flower CH; Maynard AA
J Rheumatol; 2013 Aug; 40(8):1406. PubMed ID: 23908532
[No Abstract] [Full Text] [Related]
19. [Retrospective analysis of anti-TIF1gamma, anti-NXP2 and anti-SAE1/2 antibodies carriers at Bordeaux university hospital from November 2014 to February 2017].
Victor J; Zanardo L; Héron-Mermin D; Poursac N; Solé G; Bordes C; Duffau P
Rev Med Interne; 2019 Feb; 40(2):70-81. PubMed ID: 30527961
[TBL] [Abstract][Full Text] [Related]
20. Anti-NXP2-Positive Paraneoplastic Dermatomyositis With Histopathologic Changes Confined to the Acrosyringia.
Ramírez-Bellver JL; Macías E; Bernárdez C; López-Robles J; Vegas-Sánchez MD; Díaz-Recuero JL; Quiceno H; Requena L
Am J Dermatopathol; 2017 Jan; 39(1):e3-e7. PubMed ID: 28045754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
